mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
1e-05 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |